Shares of Beximco Pharmaceuticals Limited (LON:BXP – Get Free Report) hit a new 52-week low on Wednesday . The stock traded as low as GBX 31.03 ($0.40) and last traded at GBX 34 ($0.44), with a volume of 94197 shares. The stock had previously closed at GBX 33 ($0.43).
Beximco Pharmaceuticals Stock Performance
The company has a quick ratio of 0.37, a current ratio of 1.80 and a debt-to-equity ratio of 14.73. The firm has a market cap of £151.68 million, a P/E ratio of 425.00 and a beta of 0.64. The business has a fifty day simple moving average of GBX 38.03 and a 200-day simple moving average of GBX 38.47.
Beximco Pharmaceuticals Company Profile
Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies.
Read More
- Five stocks we like better than Beximco Pharmaceuticals
- The 3 Best Retail Stocks to Shop for in August
- Target Hits the Mark: Q2 Earnings Exceed Expectations
- What Does a Stock Split Mean?
- Is Tesla’s Rebound Just Starting? Why You Should Consider Buying
- What is a Low P/E Ratio and What Does it Tell Investors?
- Stanley Druckenmiller’s Latest Bet: MELI—Should You Follow Suit?
Receive News & Ratings for Beximco Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beximco Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.